We are worldwide investors in Life Science Innovation in Biotech, Medtech, Drug Delivery and Digital Health.
Employees: 1-10
Portfolio 12
| Date | Name | Website | Total Raised | Location |
| 23.12.2024 | EpilepsyGT... | epilepsygtx.com | $43M | United Kin... |
| - | Endostart | endostart.com | $11.13M | Italy, Tus... |
| - | Hyivy Heal... | hyivy.com | $3.1M | Canada, On... |
| - | SOM Biotec... | sombiotech.com | - | Spain, Cat... |
| - | Biorek S.r... | biorek.eu | - | Italy, Lom... |
| - | Leuko | leuko.com | $16.3M | United Sta... |
| - | DELPOR INC... | delpor.com | $5.7M | United Sta... |
| - | Univercell... | univercells.com | $83.57M | Belgium, H... |
| - | Neurofenix | neurofenix.com | $7.02M | United Sta... |
| - | MyAir Inc | myairgo.com | $1.2M | United Sta... |
Show more
Mentions in press and media 3
| Date | Title | Description |
| 12.06.2024 | Sensars Revolutionizes Neuromodulation Technology | Sensars, a pioneer in neuromodulation technology, secures EUR 1.1 million in funding to propel the development of its groundbreaking SENSY product. This funding opens doors to advanced solutions for chronic pain relief, offering a ray of ho... |
| 11.06.2024 | Sensars secures investment and two grants worth EUR 1.1 million | Sensars’ latest Eurostars project, titled SENSOLE and supported by a €500,000 grant, aims to develop the world's first system capable of monitoring and treating gait disabilities and pain in patients afflicted with leg neuropathy-induced s... |
| 30.08.2022 | UK-based Neurofenix gets $7 million shot from AlbionVC to boost digital rehab platform | Currently, over 75% of neurologically injured patients, including stroke to traumatic brain injury and spinal cord injury survivors, face long-term disabilities and a lack of functionality because of insufficient neurorehabilitation. In-pat... |